MentionFox
Home › funding signals › Monocacy Therapeutics Inc.
Form D · on the record

Monocacy Therapeutics Inc. — $125K Form D filing, August 2026

Monocacy Therapeutics Inc. filed a Form D with the Securities and Exchange Commission on 2026-08-28.

Get the full cited report on Monocacy Therapeutics Inc.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

See a sample report

Just raised? Share it.

Monocacy Therapeutics Inc.: Raised $125K, Form D filed 2026-08-28

What do you want to do with Monocacy Therapeutics Inc.?

Key facts

  • · Form D filed with the SEC · Form D
  • · Sold to date: $125K · Form D
  • · Total offering: $125K · Form D
  • · First sale: Yet to occur · Form D
  • · Investors already in: 5 · Form D

Monocacy Therapeutics Inc.

New Form D on file · 2026-08-28 · the record

$125K
raise on the record
D
filing
5
investors in
MARYLAND
based
Open the record →

What the record says

FilingForm D
Filed2026-08-28
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
Year formed2025
BasedMONROVIA, MARYLAND
CIK2137361
Accession0002137361-26-000003
Filing history · 5 filings on this registrant
Form D · 2026-05-27 · $114KForm D · 2026-08-28 · $150KForm D · 2026-08-28 · $125K · this pageForm D/A, amended · 2026-08-28 · $114KForm D · 2026-09-21 · $49 2026-05-27 2026-09-21

A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.

Biotechnology · by week
This raise, $125K, filed week of Aug 24

Trailing twelve months. 759 filings in Biotechnology, totalled by week. The dot is this raise, $125K, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Monocacy Therapeutics Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Monocacy Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Monocacy Therapeutics Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on Target: the verdict, 16 sections, 39 cited sources, dated 2026-09-28A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Monocacy Therapeutics Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Monocacy Therapeutics Inc.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/funding/monocacy-therapeutics-inc-form-d-26000003
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2
Monocacy Therapeutics Inc. raised $125K — SEC Form D filing, August 2026. MentionFox, 2026-09-26. https://mentionfox.com/funding/monocacy-therapeutics-inc-form-d-26000003